Zobrazeno 1 - 10
of 46
pro vyhledávání: '"S. Flammia"'
Autor:
F. Del Giudice, M. Pecoraro, S. Cipollari, S. Flammia, A. Sciarra, C. Leonardo, M. Gallucci, E. De Berardinis, V. Panebianco
Publikováno v:
European Urology Open Science, Vol 20, Iss , Pp S160- (2020)
Externí odkaz:
https://doaj.org/article/c81cdd9649e549af9b041d5555ea4283
Autor:
G. Tuderti, R. Mastroianni, S. Flammia, M. Ferriero, C. Leonardo, U. Anceschi, A. Brassetti, S. Guaglianone, M. Gallucci, G. Simone
Publikováno v:
European Urology Open Science, Vol 19, Iss , Pp e2350- (2020)
Externí odkaz:
https://doaj.org/article/2b921b0a959244868010197f38cc79d6
Autor:
R S, Flammia, D, Lavigne, Z, Tian, F, Saad, U, Anceschi, M, Gallucci, C, Leonardo, F, Preisser, P, Mandel, F K H, Chun, P I, Karakiewicz, G, Delouya, D, Taussky, B, Hoeh
Publikováno v:
Clinical Oncology. 35:e77-e84
There is a widespread belief that outcomes of cancer patients treated within clinical trials might not be representative of the outcomes obtained within standard clinical settings. We sought to investigate the effect of trial participation on biochem
Autor:
Gabriele Sorce, Benedikt Hoeh, Rocco S. Flammia, Francesco Chierigo, Lukas Hohenhorst, Andrea Panunzio, Nancy Nimer, Zhe Tian, Giorgio Gandaglia, Derya Tilki, Carlo Terrone, Michele Gallucci, Felix K. H. Chun, Alessandro Antonelli, Fred Saad, Shahrokh F. Shariat, Francesco Montorsi, Alberto Briganti, Pierre I. Karakiewicz
Publikováno v:
The Prostate. 82:1210-1218
The numbers needed to image to identify pelvic lymph node and/or distant metastases in newly diagnosed prostate cancer (PCa) patients according to risk level are unknown.Relying on Surveillance, Epidemiology, and End Results (2010-2016), we tabulated
Autor:
Rocco S. Flammia, Benedikt Hoeh, Gabriele Sorce, Francesco Chierigo, Lukas Hohenhorst, Zhen Tian, Jordan A. Goyal, Costantino Leonardo, Alberto Briganti, Markus Graefen, Carlo Terrone, Fred Saad, Shahrokh F. Shariat, Francesco Montorsi, Felix K. H. Chun, Michele Gallucci, Pierre I. Karakiewicz
Publikováno v:
The Prostate. 82:1051-1059
Contemporary seminal vesicle invasion (SVI) rates in National Cancer Comprehensive Network (NCCN) high-risk prostate cancer (PCa) patients are not well known but essential for treatment planning. We examined SVI rates according to individual patient
Autor:
Francesco Chierigo, Marco Borghesi, Christoph Würnschimmel, Rocco S. Flammia, Benedikt Horlemann, Gabriele Sorce, Benedikt Hoeh, Zhe Tian, Fred Saad, Markus Graefen, Michele Gallucci, Alberto Briganti, Francesco Montorsi, Felix K. H. Chun, Shahrokh F. Shariat, Guglielmo Mantica, Nazareno Suardi, Carlo Terrone, Pierre I. Karakiewicz
Publikováno v:
The Prostate. 82:740-750
To compare overall mortality (OM), cancer-specific mortality (CSM), and other cause mortality (OCM) rates between radical prostatectomy (RP) versus radiotherapy (RT) in clinical node-positive (cN1) prostate cancer (PCa).Within Surveillance, Epidemiol
Autor:
F. Del Giudice, M. Pecoraro, M. Bicchetti, G. Giannarini, A. Briganti, B.I. Chung, S. Flammia, A. Sciarra, C. Leonardo, E. De Berardinis, C. Catalano, V. Panebianco
Publikováno v:
European Urology. 83:S1531-S1532
Autor:
F. Del Giudice, S. Flammia, M. Pecoraro, M. Bicchetti, S. Lucciola, B.I. Chung, B. Bucca, F. Proietti, L.C. Licari, E. Bologna, V. Asero, C.M. Scornajenghi, E. De Berardinis, A. Sciarra, C. Catalano, V. Panebianco, C. Leonardo
Publikováno v:
European Urology. 83:S1538-S1539
Autor:
Benedikt Hoeh, Rocco S. Flammia, Lukas Hohenhorst, Gabriele Sorce, Francesco Chierigo, Andrea Panunzio, Zhe Tian, Fred Saad, Michele Gallucci, Alberto Briganti, Carlo Terrone, Shahrokh F. Shariat, Markus Graefen, Derya Tilki, Alessandro Antonelli, Luis A. Kluth, Andreas Becker, Felix K. H. Chun, Pierre I. Karakiewicz
Publikováno v:
Journal of Surgical Oncology
Background and objectives: to test for differences in perioperative outcomes and total hospital costs (THC) in nonmetastatic bladder cancer patients undergoing open (ORC) versus robotic-assisted radical cystectomy (RARC). Methods: we relied on the Na
Autor:
Rocco S. Flammia, Benedikt Hoeh, Lukas Hohenhorst, Gabriele Sorce, Francesco Chierigo, Andrea Panunzio, Zhe Tian, Fred Saad, Costantino Leonardo, Alberto Briganti, Alessandro Antonelli, Carlo Terrone, Shahrokh F. Shariat, Umberto Anceschi, Markus Graefen, Felix K. H. Chun, Francesco Montorsi, Michele Gallucci, Pierre I. Karakiewicz
Publikováno v:
International urology and nephrology. 54(10)
Background Upgrading and/or upstaging in low-risk prostate cancer (PCa) patients may represent an indication for active treatment instead of active surveillance (AS). We addressed contemporary upgrading and/or upstaging rates in a large population ba